DUL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Alnylam Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 227.2 EUR -0.42% Market Closed

Market Cap: €17.6B

A	Alnylam Pharmaceuticals Inc XMUN:DUL	US
D	Dexcom Inc F:DC4	US
S	Shiseido Co Ltd XMUN:SHD	JP
	TuSimple Holdings Inc OTC:TSPH	US
E	Eastman Chemical Co XMUN:EAC	US
	Haier Smart Home Co Ltd F:HAI0	CN
M	Metacon AB (publ) F:M16	SE
C	Cohu Inc F:CU3	US
	Fanuc Corp F:FUCA	JP

Profitability Summary

Alnylam Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

84%

Declining Gross Margin

81% > 80%

Healthy Operating Margin

20%

Negative 3Y Average Operating Margin

-1%

Operating Margin is Increasing

-73% > 20%

Healthy Net Margin

17%

Negative 3Y Average Net Margin

-7%

Net Margin is Increasing

-86% > 17%

Exceptional Free Cash Flow Margin

17%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-44% > 17%

Exceptional ROE

101%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.